A higher expression of TMPRSS6 or CLDN10 individually could be detected in other tumors (Supplementary Figures 4A, B respectively), while a higher combined expression was observed in ovarian serous cystadenocarcinoma (OV), thyroid carcinoma (THCA), and uterine corpus endometrial carcinoma (UCEC) apart from LUAD (Supplementary Figure 4C). Here, CLDN10 is linked to uterine corpus endometrial carcinoma.